Development of Triple Artemisinin Combination Therapies (DeTACT), to accelerate the development of two new triple artemisinin combination therapies for malaria.
Description
This activity Development of Triple Artemisinin Combination Therapies (DeTACT), to accelerate the development of two new triple artemisinin combination therapies for malaria. is a component of Product Development Research programme (PDPs) reported by FCDO with a funding type of 111 - Not for profit organisation and a budget of £8,807,909. This project benefits Developing countries, unspecified. It works in the following sector(s): Medical research.
Location
The country, countries or regions that benefit from this Programme.
Status Post-completion
The current stage of the Programme, consistent with the International Aid Transparency Initiative's (IATI) classifications.
Programme Spend
Programme budget and spend to date, as per the amounts loaded in financial system(s), and for which procurement has been finalised.
Participating Organisation(s)
Help with participating organisations
Accountable:Organisation responsible for oversight of the activity
Extending: Organisation that manages the budget on behalf of the funding organisation.
Funding: Organisation which provides funds.
Implementing: Organisations implementing the activity.
- Accountable
- Funding
- Implementing
Sectors
Sector groups as a percentage of total Programme budget according to the OECD Development Assistance Committee (DAC) classifications.
Budget
A comparison across financial years of forecast budget and spend to date on the Programme.
Download IATI Data for GB-GOV-1-300341-114